257 related articles for article (PubMed ID: 7488316)
1. Anti-platelet effects of isocarbacyclin methyl ester on human and rabbit platelets in vitro.
Inoue K; Aoki Y; Kitahara S; Kiyoki M; Araki H
Arzneimittelforschung; 1995 Sep; 45(9):975-9. PubMed ID: 7488316
[TBL] [Abstract][Full Text] [Related]
2. Exhibition of anti-platelet effect of isocarbacyclin methyl ester and its free acid via an increase in cAMP in platelets.
Aoki Y; Inoue K; Kitahara S; Kiyoki M; Araki H
Arzneimittelforschung; 1995 Sep; 45(9):970-4. PubMed ID: 7488315
[TBL] [Abstract][Full Text] [Related]
3. Ex vivo anti-platelet effects of isocarbacyclin methyl ester incorporated in lipid microspheres in rabbits.
Inoue K; Aoki Y; Hayashi M; Kitahara S; Tanabe H; Kiyoki M; Araki H
Arzneimittelforschung; 1995 Sep; 45(9):980-4. PubMed ID: 7488317
[TBL] [Abstract][Full Text] [Related]
4. Vasorelaxant effect of isocarbacyclin methyl ester incorporated into lipid microspheres on isolated canine arteries.
Sawada K; Aoki K; Katsuura Y; Tanabe H; Kiyoki M; Araki H
Arzneimittelforschung; 1995 Sep; 45(9):985-8. PubMed ID: 7488318
[TBL] [Abstract][Full Text] [Related]
5. In vitro studies with the stabilized epoprostenol analogue taprostene. Effect on platelets and erythrocytes.
Michel G; Seipp U
Arzneimittelforschung; 1990 Jul; 40(7):817-22. PubMed ID: 2222558
[TBL] [Abstract][Full Text] [Related]
6. Effect of isocarbacyclin methyl ester incorporated into lipid microspheres on cutaneous blood flow in rat.
Sawada K; Taneda K; Katsuura Y; Tanabe H; Kiyoki M; Araki H
Arzneimittelforschung; 1995 Sep; 45(9):988-90. PubMed ID: 7488319
[TBL] [Abstract][Full Text] [Related]
7. The in-vitro effect of tirofiban, glycoprotein IIb/IIIa antagonist, on various responses of porcine blood platelets.
Ciborowski M; Tomasiak M; Rusak T; Winnicka K; Dobrzycki S
Blood Coagul Fibrinolysis; 2008 Sep; 19(6):557-67. PubMed ID: 18685439
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological properties of the new stable prostacyclin analogue 3-Oxa-methano-prostaglandin I.
Yamamoto T; Satoh K; Nishimura T; Horikawa N; Mine T; Hirohashi T; Hara Y
Arzneimittelforschung; 1994 Apr; 44(4):483-90. PubMed ID: 8011001
[TBL] [Abstract][Full Text] [Related]
9. In vivo studies with the stabilized epoprostenol analogue taprostene. Effects on platelet functions and blood clotting.
Michel G; Seipp U
Arzneimittelforschung; 1990 Aug; 40(8):932-8. PubMed ID: 2242087
[TBL] [Abstract][Full Text] [Related]
10. Effects of bupranolol, a new beta-blocker, on platelet functions of rabbit and human in vitro.
Umetsu T; Sanai K; Kato T
Thromb Haemost; 1976 Nov; 36(2):376-87. PubMed ID: 12593
[TBL] [Abstract][Full Text] [Related]
11. Prostaglandin releasing polymers - stability and efficacy.
McRea JC; Ebert CD; Kim SW
Trans Am Soc Artif Intern Organs; 1981; 27():511-6. PubMed ID: 7036503
[TBL] [Abstract][Full Text] [Related]
12. Effects of prostacyclin on tumor cell-induced platelet aggregation.
Menter DG; Onoda JM; Taylor JD; Honn KV
Cancer Res; 1984 Feb; 44(2):450-6. PubMed ID: 6362850
[TBL] [Abstract][Full Text] [Related]
13. [Effect of protopine on rabbit platelet function].
Ma GY; Zhang ZZ; Chen ZH
Zhongguo Yao Li Xue Bao; 1994 Jul; 15(4):367-71. PubMed ID: 7801784
[TBL] [Abstract][Full Text] [Related]
14. The fibrinogen gamma chain dodecapeptide inhibits agonist-induced aggregation of rabbit platelets and fibrinogen binding to rabbit glycoprotein IIb-IIIa.
Rand ML; Packham MA; Taylor DM; Yeo EL; Gemmell CH; Patil S; Lam SC
Thromb Haemost; 1999 Dec; 82(6):1680-6. PubMed ID: 10613655
[TBL] [Abstract][Full Text] [Related]
15. Potentiation of antiaggregating effect of prostaglandins by alpha-tocopherol and quercetin.
Mardla V; Kobzar G; Samel N
Platelets; 2004 Aug; 15(5):319-24. PubMed ID: 15370103
[TBL] [Abstract][Full Text] [Related]
16. ADP-mimicking platelet aggregation caused by rugosin E, an ellagitannin isolated from Rosa rugosa Thunb.
Teng CM; Kang YF; Chang YL; Ko FN; Yang SC; Hsu FL
Thromb Haemost; 1997 Mar; 77(3):555-61. PubMed ID: 9066010
[TBL] [Abstract][Full Text] [Related]
17. Effect of a stable prostacyclin analogue on platelet function and experimentally-induced thrombosis in the microcirculation.
Sim AK; McCraw AP; Cleland ME; Nishio S; Umetsu T
Arzneimittelforschung; 1985; 35(12):1816-8. PubMed ID: 3913423
[TBL] [Abstract][Full Text] [Related]
18. Comparison of anti-aggregatory effects of PGI2, PGI3 and iloprost on human and rabbit platelets.
Kobzar G; Mardla V; Järving I; Samel N
Cell Physiol Biochem; 2001; 11(5):279-84. PubMed ID: 11684817
[TBL] [Abstract][Full Text] [Related]
19. Anti-platelet and anti-thrombotic effects of OP-41483.alpha-CD, a prostacyclin analogue, in experimental animals.
Katsube N; Sakaguchi K; Fujitani B; Aishita H
Prostaglandins Leukot Essent Fatty Acids; 1993 Oct; 49(4):795-804. PubMed ID: 8259376
[TBL] [Abstract][Full Text] [Related]
20. Effects of prostaglandin E1 on platelet attenuation of oxidant-induced edema in isolated rabbit lungs.
Heffner JE; Baron DA
J Lab Clin Med; 1990 Dec; 116(6):797-804. PubMed ID: 2246556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
